SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D
                                  Rule 13d-101

                   Under the Securities Exchange Act of 1934
                               (Amendment No. 6)*

                              Raytech Corporation
--------------------------------------------------------------------------------
                                (Name of Issuer)

                    Common Stock, $1.00 par value per share
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   755103108
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                           Richard A. Lippe, Trustee
         Raytech Corporation Asbestos Personal Injury Settlement Trust
                c/o Meltzer, Lippe, Goldstein & Breitstone, LLP
                               190 Willis Avenue
                               Mineola, NY 11501
                                 (516) 747-0300
--------------------------------------------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)

                                   07/07/2005
--------------------------------------------------------------------------------
            (Date of Event which Requires Filing of this Statement)

--------------------------------------------------------------------------------
      If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. |_|

      NOTE: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7 for other
parties to whom copies are to be sent.

      * The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.

      The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).

Page 1 of 4 Pages


CUSIP No. 755103108
--------------------------------------------------------------------------------
(1) Names and I.R.S. Identification Nos.(entities only) of reporting persons.

    Raytech Corporation Asbestos Personal Injury Trust
--------------------------------------------------------------------------------
(2) Check the appropriate box if a member of a group (see instructions)   (a)|_|
                                                                          (b)|X|
--------------------------------------------------------------------------------
(3) SEC use only.

--------------------------------------------------------------------------------
(4) Source of funds (see instructions).

    WC 
--------------------------------------------------------------------------------
(5) Check if disclosure of legal proceedings is required pursuant to Items   |_|
    2(d) or 2(e).                                                             
--------------------------------------------------------------------------------
(6) Citizenship or place of organization.

    New York
--------------------------------------------------------------------------------
Number of shares beneficially owned by each reporting person with:

    (7) Sole voting power:
        37,813,320 (1)

    (8) Shared voting power:
        N/A

    (9) Sole dispositive power:
        37,813,320 (1)

    (10) Shared dispositive power:
         N/A

--------------------------------------------------------------------------------
(11) Aggregate amount beneficially owned by each reporting person.

     37,813,320 (1)
--------------------------------------------------------------------------------
(12) Check if the aggregate amount in Row (11) excludes certain shares       |_|
     (see instructions). 
--------------------------------------------------------------------------------
(13) Percent of class represented by amount in Row (11).

     90.6% (1)
--------------------------------------------------------------------------------
(14) Type of reporting person (see instructions).

     OO
--------------------------------------------------------------------------------

----------
(1)     Includes 3,228,888 shares of Common Stock of the Issuer to be acquired
        by the Reporting Person in the manner more fully described in Item 4
        below.

Page 2 of 4 Pages


Item 1. Security and Issuer.

           This Amendment No. 6 amends and supplements the Schedule 13D filed
           on February 15, 2002 (the "Schedule 13D") by the Reporting Person
           with respect to the common stock, par value $1.00 per share (the
           "Common Stock") of the Issuer.  All capitalized terms used herein but
           not otherwise defined have the meanings given to such terms in the
           Schedule 13D.

Item 2. Identity and Background.

          (a) N/A

          (b) N/A

          (c) N/A

          (d) N/A

          (e) N/A

          (f) N/A

Item 3. Source and Amount of Funds or Other Consideration.

           The information provided in response to Item 4 below is incorporated
           herein by reference.

Item 4. Purpose of Transaction.

           In connection with the plan of Raytech Corporation, Case No.
           89-00293, confirmed by the United States Bankruptcy Court for the
           District of Connecticut (the "Bankruptcy Court") on August 31, 2000,
           we entered into an Agreement, dated June 8, 2000 (the "2000
           Agreement"), and Settlement Agreement, dated October 31, 2001 (the
           "2001 Agreement"), with the United States Environmental Protection
           Agency, the Connecticut Department of Environmental Protection, and
           FMC Corporation (collectively, the "Environmental Creditors") to
           mutually resolve claims against the Issuer, Raymark Industries, Inc.
           and Raymark Corporation.  In consideration for the compromise of the
           Environmental Creditors' claims, we entered into a Supplemental
           Settlement Agreement, dated as of May 25, 2005 (the "2005
           Agreement"), with the Environmental Creditors, which was fully
           executed and delivered by the parties on July 7, 2005, whereby we
           agreed to accelerate the settlement of the claims as originally set
           forth in the 2000 Agreement and 2001 Agreement. The 2005 Agreement
           accelerates the assignment by the Environmental Creditors, and the
           acquisition by the Trust (the "Acquisition"), of, among other things,
           (i) 3,228,888 shares of Common Stock (representing 7.6% of the issued
           and outstanding Common Stock of the Issuer), (ii) claims to certain
           assets of Raymark Industries, Inc., Raymark Corporation and Universal
           Friction Composites (formerly related companies of the Issuer) and
           (iii) tax benefits currently owned by the Environmental Creditors.
           As agreed to in the 2001 Agreement, in exchange for the shares of
           Common Stock, other assets and tax benefits, the Trust will pay the
           Environmental Creditors cash consideration of $9,457,776.  
           
           The Acquisition is the first step in a series of transactions by
           which the Trust intends to take the Issuer private through a
           going-private transaction. The closing of the transactions
           contemplated by the 2005 Agreement is subject to approval by the
           Bankruptcy Court of the 2005 Agreement and the final disposition of
           all comments of the SEC on the Trust's Schedule 13E-3 with respect to
           the going-private transaction involving the Issuer.  A copy of the
           2005 Agreement is attached to this Amendment No. 6 as Exhibit 8.
           
           After the consummation of the Acquisition described above, the Trust
           will increase its beneficial ownership of Common Stock to 37,813,320
           shares (or 90.6% of the Issuer's outstanding shares). The Trust
           intends to merge the Issuer with a subsidiary, wholly owned by the
           Trust, under the Delaware short-form merger statutes (the "Merger").
           It is the intent of the Trust, and the purpose of the Acquisition and
           the Merger, to cause the Issuer to file a Form 15 to deregister its
           Common Stock under the Exchange Act and to delist its Common Stock
           from the New York Stock Exchange.  
           
           Working capital of the Trust will used to pay the consideration to be
           provided to the Environmental Creditors in the Acquisition and the
           public shareholders in the Merger. 


Item 5. Interest in Securities of the Issuer.

          (a) The information provided in response to Item 4 above is
              incorporated herein by reference.

          (b) The information provided in response to Item 4 above is
              incorporated herein by reference.

          (c) N/A

          (d) N/A

          (e) N/A

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to
        Securities of the Issuer.

           The information provided in response to Item 4 above is incorporated
           herein by reference.  The 2005 Agreement discussed in Item 4 above is
           filed as Exhibit 99.8.

Item 7. Material to be Filed as Exhibits.

           EXHIBIT NUMBER                    TITLE
           
                 8                  Supplemental Settlement Agreement, 
                                    dated of May  25, 2005 and
                                    executed and delivered July 7, 
                                    2005, between the Raytech
                                    Corporation Asbestos Personal
                                    Injury Settlement Trust and 
                                    the Environmental Creditors

Page 3 of 4 Pages


After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

                                      Raytech Corporation Asbestos Personal
                                      Injury Settlement Trust

Date: 07/11/2005                      /s/ Richard A. Lippe
                                      Name:  Richard A. Lippe
                                      Title: Managing Trustee


The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement: Provided, however, That a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.

ATTENTION--Intentional misstatements or omissions of fact constitute Federal
criminal violations (See 18 U.S.C. 1001). (Secs. 13(d), 13(g), 14(d), 23, 48
Stat. 894, 895, 901; sec. 8, 49 Stat. 1379; sec. 203(a), 49 Stat. 704; sec. 10,
78 Stat. 88a; Secs. 2, 3, 82 Stat. 454, 455; secs. 1, 2, 3-5, 84 Stat. 1497;
sec. 18, 89 Stat. 155; secs. 202, 203, 91 Stat. 1494, 1498, 1499; 15 U.S.C.
78m(d), 78m(g), 78n(d), 78w) [44 FR 2145, Jan. 9, 1979; 44 FR 11751, Mar. 2,
1979; 44 FR 70340, Dec. 6, 1979; 47 FR 11466, Mar. 16, 1982; 61 FR 49959, Sept.
24, 1996; 62 FR 35340, July 1, 1997; 63 FR 2867, Jan. 16, 1998; 63 FR 15287,
Mar. 31, 1998]

Page 4 of 4 Pages